Cryo Cell International (CCEL) Share-based Compensation: 2010-2024
Historic Share-based Compensation for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $781128.0.
- Cryo Cell International's Share-based Compensation fell 7479.8% to $36780.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $414172.0, marking a year-over-year decrease of 4882.32%. This contributed to the annual value of $781128.0 for FY2024, which is 439.07% down from last year.
- Per Cryo Cell International's latest filing, its Share-based Compensation stood at $781128.0 for FY2024, which was down 439.07% from $817000.0 recorded in FY2023.
- Cryo Cell International's 5-year Share-based Compensation high stood at $817000.0 for FY2023, and its period low was $302000.0 during FY2021.
- Moreover, its 5-year median value for Share-based Compensation was $622120.0 (2020), whereas its average is $596718.6.
- Its Share-based Compensation has fluctuated over the past 5 years, first tumbled by 5145.63% in 2021, then surged by 7709.09% in 2023.
- Over the past 5 years, Cryo Cell International's Share-based Compensation (Annual) stood at $622120.0 in 2020, then tumbled by 51.46% to $302000.0 in 2021, then soared by 52.76% to $461345.0 in 2022, then surged by 77.09% to $817000.0 in 2023, then dropped by 4.39% to $781128.0 in 2024.
- Its last three reported values are $781128.0 in FY2024, $817000.0 for FY2023, and $461345.0 during FY2022.